Evidence map›Paper›PMID 21852536›Full record

ArticleGenes & development2011

Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.

Alexandra R Grassian, Christian M Metallo, Jonathan L Coloff, Gregory Stephanopoulos, Joan S Brugge

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 187 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Engineering metabolism to modulate immunity.Advanced drug delivery reviews · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alexandra R GrassianDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Christian M Metallo
Jonathan L Coloff
Gregory Stephanopoulos
Joan S Brugge
Harvard University · USMassachusetts Institute of Technology · US

Funding

Cell Death Regulation in Lumen Formation and OncogenesisR01CA105134 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BRUGGE, JOAN SIEFERT · 2003 to 2012
$4.1M
NCI NIH HHS CA105134NCI NIH HHS R01 CA105134
6 · The paper itself

Abstract

Loss of extracellular matrix (ECM) attachment leads to metabolic impairments that limit cellular energy production. Characterization of the metabolic alterations induced by ECM detachment revealed a dramatic decrease in uptake of glucose, glutamine, and pyruvate, and a consequent decrease in flux through glycolysis, the pentose phosphate pathway, and the tricarboxylic acid (TCA) cycle. However, flux through pyruvate dehydrogenase (PDH) is disproportionally decreased, concomitant with increased expression of the PDH inhibitory kinase, PDH kinase 4 (PDK4), and increased carbon secretion. Overexpression of ErbB2 maintains PDH flux by suppressing PDK4 expression in an Erk-dependent manner, and Erk signaling also regulates PDH flux in ECM-attached cells. Additionally, epidermal growth factor (EGF), a potent inducer of Erk, positively regulates PDH flux through decreased PDK4 expression. Furthermore, overexpression of PDK4 in ECM-detached cells suppresses the ErbB2-mediated rescue of ATP levels, and in attached cells, PDK4 overexpression decreases PDH flux, de novo lipogenesis, and cell proliferation. Mining of microarray data from human tumor data sets revealed that PDK4 mRNA is commonly down-regulated in tumors compared with their tissues of origin. These results identify a novel mechanism by which ECM attachment, growth factors, and oncogenes modulate the metabolic fate of glucose by controlling PDK4 expression and PDH flux to influence proliferation.

Indexed as

Cell ProliferationAdenosine TriphosphateAnimalsCell AdhesionCell LineCitric Acid CycleEpidermal Growth FactorErb-b2 Receptor Tyrosine KinasesExtracellular MatrixExtracellular Signal-Regulated MAP KinasesGlucoseHumansImmunoblottingInsulinMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Adenosine TriphosphateEpidermal Growth FactorErb-b2 Receptor Tyrosine KinasesExtracellular Signal-Regulated MAP KinasesGlucoseInsulinMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Protein KinasesPyruvate Dehydrogenase Complexpyruvate dehydrogenase kinase 4Pyruvic Acid

Identifiers

PMID21852536
PMCPMC3165936
OpenAlexW2172296717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.